Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other 1Gastrointestinal 1Dermatologic 1

Conditions

Obesity 218Neoplasms 73Breast Neoplasms 66Overweight 65Sexual Dysfunction, Physiological 51Motor Activity 43Polycystic Ovary Syndrome 42Weight Loss 32Mucositis 29Dyspnea 28Prostatic Neoplasms 22Multiple Endocrine Neoplasia Type 1 16Constipation 15Lung Neoplasms 14Endometrial Neoplasms 14Diabetes Mellitus 14Anxiety Disorders 14Sedentary Behavior 13Depression 13Sexual Dysfunctions, Psychological 12Cardiovascular Diseases 12Pain 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Fatigue 10Diabetes Mellitus, Type 2 10Colorectal Neoplasms 10Sexuality 9Obesity, Morbid 9Insulin Resistance 9Head and Neck Neoplasms 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Herpes Zoster × Other × Clear all
NCT04540081 2023-12-27

CLOVER

University of California, Davis

Phase NA Completed
20,000 enrolled
GastrointestinalOtherThoracic

Colonic Neoplasms, Hepatitis C, Herpes Zoster, Lung Neoplasms, Obesity, Pneumonia, Bacterial, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡